Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Gozzo

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Frontiers in Pharmacology|June 29, 2026
Off-label prescribing in ophthalmology: a retrospective analysisClaudio Bucolo, Lucia Gozzo, Laura Terranova, et al.
Current Neuropharmacology|June 30, 2021
SARS-Cov-2 Damage on the Nervous System and Mental HealthMohamed Said Boulkrane, Victoria Ilina, Roman Melchakov, et al.
Frontiers in Pharmacology|January 4, 2021
COVID-19 Disease and Vitamin D: A Mini-ReviewMohamed Said Boulkrane, Victoria Ilina, Roman Melchakov, et al.
Cancers|January 11, 2022
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?Serena Brancati, Lucia Gozzo, Giovanni Luca Romano, et al.
Pharmacological Research|May 28, 2014
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axisAndrea Navarria, Alessandra Tamburella, Fabio A Iannotti, et al.
JMIR Formative Research|May 5, 2026
Understanding Online Health Information Consumption Through Web Analytics of the Italian Society of Pharmacology Magazine: 3-Year Descriptive AnalysisAgnese Graziosi, Michele Santoni, Luigi Cari, et al.
European Journal of Dentistry|December 13, 2022
Periodontal Disease and Pregnancy: Correlation with Underweight BirthGiuseppe Minervini, Manuele Basili, Rocco Franco, et al.
Cancer Medicine|April 23, 2020
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)Massimo Breccia, Pier Paolo Olimpieri, Odoardo Olimpieri, et al.
Journal of Clinical Medicine|July 29, 2025
Real-World Outcomes in <i>FLT3</i>-ITD Mutated Acute Myeloid Leukemia: Impact of NPM1 Mutations and Allogeneic Transplantation in a Retrospective Unicentric CohortVeronica Vecchio, Andrea Duminuco, Salvatore Leotta, et al.
Biomedicines|October 23, 2021
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic ReviewMario Damiano Toro, Lucia Gozzo, Luciano Tracia, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Frontiers in Pharmacology|June 29, 2026
Off-label prescribing in ophthalmology: a retrospective analysisClaudio Bucolo, Lucia Gozzo, Laura Terranova, et al.
Current Neuropharmacology|June 30, 2021
SARS-Cov-2 Damage on the Nervous System and Mental HealthMohamed Said Boulkrane, Victoria Ilina, Roman Melchakov, et al.
Frontiers in Pharmacology|January 4, 2021
COVID-19 Disease and Vitamin D: A Mini-ReviewMohamed Said Boulkrane, Victoria Ilina, Roman Melchakov, et al.
Cancers|January 11, 2022
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?Serena Brancati, Lucia Gozzo, Giovanni Luca Romano, et al.
Pharmacological Research|May 28, 2014
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axisAndrea Navarria, Alessandra Tamburella, Fabio A Iannotti, et al.
JMIR Formative Research|May 5, 2026
Understanding Online Health Information Consumption Through Web Analytics of the Italian Society of Pharmacology Magazine: 3-Year Descriptive AnalysisAgnese Graziosi, Michele Santoni, Luigi Cari, et al.
European Journal of Dentistry|December 13, 2022
Periodontal Disease and Pregnancy: Correlation with Underweight BirthGiuseppe Minervini, Manuele Basili, Rocco Franco, et al.
Cancer Medicine|April 23, 2020
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)Massimo Breccia, Pier Paolo Olimpieri, Odoardo Olimpieri, et al.
Journal of Clinical Medicine|July 29, 2025
Real-World Outcomes in <i>FLT3</i>-ITD Mutated Acute Myeloid Leukemia: Impact of NPM1 Mutations and Allogeneic Transplantation in a Retrospective Unicentric CohortVeronica Vecchio, Andrea Duminuco, Salvatore Leotta, et al.
Biomedicines|October 23, 2021
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic ReviewMario Damiano Toro, Lucia Gozzo, Luciano Tracia, et al.
Pageof 5